Monitoring Heart Rhythms after a Stroke
Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke
Recruiting
N/A
Interventional Study
Paroxysmal Atrial Fibrillation
Cardiac Rhythm Disorder
Left Atrial Dilatation
Cryptogenic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 89
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Parc de Salut Mar · Other
Who this trial is looking for
This trial is looking for patients who have had a stroke or a mini-stroke and may have invisible heart rhythm problems. Participants will have heart monitors to help detect these issues early.
Are You a Good Fit for This Trial?
You may be able to join if
- I have had a stroke or mini-stroke since January 2022.
- I am between 50 and 89 years old.
- My stroke is of an unknown cause according to certain medical criteria.
- I have normal results from heart ultrasound tests.
- I have not had atrial fibrillation detected during a 48-hour heart monitor.
- I have normal findings from ultrasound of the arteries in my neck.
You may not be able to join if
- I have had a bleeding stroke before.
- I have been diagnosed with atrial fibrillation or flutter in the past.
- I cannot take blood thinners for any reason.
- I have had major surgery or heart events in the past month.
- I have severe heart problems.
- I am expected to live less than a year.
- My stroke was very severe.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cryptogenic stroke (CS) causes about 30% of admissions to a stroke unit. Silent paroxysmal atrial fibrillation (PAF) is believed to be the underlying cause of a significant proportion of patients. The use of implantable cardiac monitors (ICM) early after the CS has demonstrated benefits in the diagnostic yield, but the indication for ICM in the current guidelines remains unclear. Atrial contractio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Acute ischemic stroke or transient ischemic attack (TIA) from January 2022 to July 2023
* Age between 50 and 89 years;
* Undetermined origin at hospital admission according to the SSS-TOAST criteria (2):
1. Absence of major structural heart disease by cardiac ultrasound (no…
Contacts